Synopsis
Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers.
"synopsis" may belong to another edition of this title.
Search results for HPLC Method Development of Fingolimod
Stock Image
HPLC Method Development of Fingolimod
Published by
LAP Lambert Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Softcover
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # ABLIING23Mar3113020301056
Stock Image
HPLC Method Development of Fingolimod
Published by
LAP Lambert Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
PAP
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659693090
Stock Image
HPLC Method Development of Fingolimod
Published by
LAP Lambert Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
PAP
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659693090
Buy New
US$ 46.29
Shipping:
US$ 4.36
From United Kingdom to U.S.A.
Quantity: Over 20 available
Stock Image
HPLC Method Development of Fingolimod
Published by
LAP Lambert Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Softcover
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. In. Seller Inventory # ria9783659693090_new
Buy New
US$ 43.46
Shipping:
US$ 15.86
From United Kingdom to U.S.A.
Quantity: Over 20 available
Stock Image
HPLC Method Development of Fingolimod
Published by
LAP Lambert Academic Publishing 2015-05-18, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Paperback
Seller: Chiron Media, Wallingford, United Kingdom
Seller rating 4 out of 5 stars
Paperback. Condition: New. Seller Inventory # 6666-IUK-9783659693090
Buy New
US$ 41.54
Shipping:
US$ 20.51
From United Kingdom to U.S.A.
Quantity: 10 available
Seller Image
HPLC Method Development of Fingolimod
Published by
LAP LAMBERT Academic Publishing Mai 2015, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers. 60 pp. Englisch. Seller Inventory # 9783659693090
Seller Image
HPLC Method Development of Fingolimod
Published by
LAP LAMBERT Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Softcover
Seller: moluna, Greven, Germany
Seller rating 4 out of 5 stars
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Ghosh SomsubhraSomsubhra Ghosh is Assistant Professor in theDepartment of Pharmaceutical Analysis & QualityAssurance in Bharat Technology,Uluberia,Howrah, W.B. He has written 3 books & 34 papers indifferent reputed National & Interna. Seller Inventory # 159143802
Buy New
US$ 40.92
Shipping:
US$ 56.83
From Germany to U.S.A.
Quantity: Over 20 available
Seller Image
HPLC Method Development of Fingolimod
Published by
LAP LAMBERT Academic Publishing Mai 2015, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Taschenbuch
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch. Seller Inventory # 9783659693090
Seller Image
HPLC Method Development of Fingolimod : A new RP HPLC method developmental & validation of Fingolimod HCL
Published by
LAP LAMBERT Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Taschenbuch
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers. Seller Inventory # 9783659693090
Seller Image
HPLC Method Development of Fingolimod | A new RP HPLC method developmental & validation of Fingolimod HCL
Published by
LAP LAMBERT Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
New
Taschenbuch
Seller: preigu, Osnabrück, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. HPLC Method Development of Fingolimod | A new RP HPLC method developmental & validation of Fingolimod HCL | Somsubhra Ghosh (u. a.) | Taschenbuch | 60 S. | Englisch | 2015 | LAP LAMBERT Academic Publishing | EAN 9783659693090 | Verantwortliche Person für die EU: OmniScriptum GmbH & Co. KG, Bahnhofstr. 28, 66111 Saarbrücken, info[at]akademikerverlag[dot]de | Anbieter: preigu. Seller Inventory # 104616497